Spurr Robert
SEC CIK 1543795 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BHC | Bausch Health Companies Inc. | U.S. Pres-Pharma Business, Dir | 99.1K | — | $348.2K | 13 | 2021-08-27 | 2022-05-10 |
Most active insiders at BHC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | PAULSON & CO. INC. | 10% | $15.62M | — |
| 2 | Lenar Aimee J. | Pres, US Pharma | — | $258.9K |
| 3 | Lee Frank D. | Dir | — | $132.8K |
| 4 | Carson Seana | EVP, GC | — | $115.0K |
| 5 | LEE STEVEN HYOSIG | SVP, CAO, Ctrl | — | — |
| 6 | GOETTLER MICHAEL | Dir | — | — |
| 7 | ROBERTS EIRY | Dir | — | — |
| 8 | Charhon Jean-Jacques | EVP, CFO | — | — |
| 9 | APPIO THOMAS | CEO, Dir | — | — |
| 10 | KAVANAGH SARAH B | Dir | — | — |
Spurr Robert made no open-market trades at BHC in the last 12 months.
Transactions 13
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-05-12 | 2022-05-10 | BHC | Bausch Health Companies Inc. | Spurr Robert | Pres, U.S. Businesses | M - OptEx | — | +22.2K | 99.1K | +29% | — |
| 2022-04-15 | 2022-04-14 | BHC | Bausch Health Companies Inc. | Spurr Robert | U.S. Pres-Pharma Business | S - Sale | $22.19 | -1,595 | 90.5K | -2% | -$35.4K | |
| 2022-03-16 | 2022-03-15 | BHC | Bausch Health Companies Inc. | Spurr Robert | U.S. Pres-Pharma Business | S - Sale | $22.20 | -4,846 | 92.1K | -5% | -$107.6K | |
| 2022-03-07 | 2022-03-03 | BHC | Bausch Health Companies Inc. | Spurr Robert | U.S. Pres-Pharma Business | F - Tax | $23.61 | -4,074 | 96.9K | -4% | -$96.2K | |
| D | 2022-03-04 | 2022-03-02 | BHC | Bausch Health Companies Inc. | Spurr Robert | U.S. Pres-Pharma Business | A - Grant | $24.17 | +35.6K | 101.0K | +54% | +$861.1K |
| D | 2022-03-04 | 2022-03-02 | BHC | Bausch Health Companies Inc. | Spurr Robert | U.S. Pres-Pharma Business | S - Sale | $23.37 | -1,595 | 65.4K | -2% | -$37.3K |
| DM | 2022-03-02 | 2022-02-26+ | BHC | Bausch Health Companies Inc. | Spurr Robert | U.S. Pres-Pharma Business, Dir | F - Tax | $24.35 | -8,925 | 68.6K | -12% | -$217.3K |
| D | 2022-03-02 | 2022-02-27 | BHC | Bausch Health Companies Inc. | Spurr Robert | U.S. Pres-Pharma Business, Dir | M - OptEx | — | +15.6K | 75.9K | +26% | — |
| 2022-02-17 | 2022-02-15 | BHC | Bausch Health Companies Inc. | Spurr Robert | U.S. Pres-Pharma Business | S - Sale | $25.02 | -3,251 | 60.3K | -5% | -$81.3K | |
| 2022-01-20 | 2022-01-18 | BHC | Bausch Health Companies Inc. | Spurr Robert | U.S. Pres-Pharma Business | S - Sale | $26.63 | -3,251 | 63.5K | -5% | -$86.6K | |
| 2021-10-05 | 2021-10-01 | BHC | Bausch Health Companies Inc. | Spurr Robert | U.S. Pres-Pharma Business | F - Tax | $28.60 | -283 | 66.8K | -0.4% | -$8,094 | |
| D | 2021-09-03 | 2021-09-01 | BHC | Bausch Health Companies Inc. | Spurr Robert | Pres, Salix | A - Grant | $0.00 | +9,026 | 67.1K | +16% | $0 |
| 2021-08-31 | 2021-08-27 | BHC | Bausch Health Companies Inc. | Spurr Robert | Pres, Salix | F - Tax | $28.95 | -1,278 | 58.1K | -2% | -$37.0K |
Purchase Sale Sale after option exercise All abbreviations